Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
7,195
datasets available to search
ShareScore release 0.9.0
Dataset results
7,195 results for “SET”
Open Data sets from Cold Climate Wind Farms in Finland, Olostunturi
<p>This dataset includes 6 years of open access meteorological mast data and operational data of multiple turbines from Olos wind farm in Finland, and simultaneous and longer-term monthly icing time series from WIceAtlas database for reference. Olos is a complex terrain site with severe icing conditions during winter (IEA Ice Class 4).</p> <p>The work was funded by an EU IRPWIND project.</p>
Data used for Web of Science World Conservation Publication Index 1993 - 2016 | Biodiversity Publication Bias Compromises Setting Conservation Priorities
<p>Data used for Web of Science World Conservation Publication Index 1993 - 2016, see https://github.com/raffael-hickisch/rwosconsindex</p>
Data set associated with submitted journal article.
<p>This is a data set associated with submitted journal article. At the moment this data is intended to be open to the reviewers for potential evaluation.</p>
DATA SET FOR: From Beats to Engagement: Exploring how Individual Interest in Hip Hop Dance fuels Student Engagement in Physical Education
Open the record for dataset details and reuse information.
DATA SET FOR: Driven by Grit, Inspired by Curiosity: Enhancing Students' Academic Engagement in Physical Education in the Higher Education System
Open the record for dataset details and reuse information.
Lu Liu. Growth and defence in a unicellular microalga: the coexistence of r and K strategy. [Data set]. Zenodo.
Open the record for dataset details and reuse information.
DATA SET FOR: Interweaving Perceived Instructors' Emotional Support and Students' Academic Resilience through the lens of Mindset and Attachment Theories
Open the record for dataset details and reuse information.
Data set The Determinants of Perceived Risk: A Moderating Role of investor Sophistication
Open the record for dataset details and reuse information.
Data used for the scientific work "Effectiveness of Cognitive Behavioral Therapy in naturalistic settings for patients with and without personality disorders: a comparative study of the English IAPT and the Italian inTHERAPY programs on anxiety and depression symptoms"
Open the record for dataset details and reuse information.
Data set for "Hemoglobin, albumin, lymphocyte, and platelet score: A risk prediction tool for incidence and mortality in diabetic kidney disease patients with type 2 diabetes "
Open the record for dataset details and reuse information.
Sexuality Knowledge Assessment Questionnaire (SEKAQ): importance of the school setting in health education
Open the record for dataset details and reuse information.
NGFS Climate Scenarios Data Set
<h1><strong>Notice to users of NGFS long-term climate scenarios</strong></h1> <p>The NGFS informs users that the academic paper underpinning the physical risk estimates in Phase V of its long-term scenarios, Kotz et al. (2024), has received critiques in a post-publication review at <em>Nature</em>. The authors have revised their analysis, with limited impacts on results. The updated paper still has to undergo peer-review.</p> <p>The NGFS closely monitors the academic process and will incorporate any necessary updates in future iterations of its long-term scenarios.</p> <p>Users are reminded that neither the NGFS, nor its member institutions, nor any person acting on their behalf, is responsible or liable for any reliance on, or for any use of the NGFS scenarios and/or supplementary documentation. This also applies to the use of the data produced under the scenarios – see section 5 in <a title="https://protect.checkpoint.com/v2/r02/___https://data.ene.iiasa.ac.at/ngfs/%23/license___.YzJlOmlpYXNhOmM6bzpkYjlkNzM0YWJiNzc3OTZkOWFhNjVkMzJlOGU5OWMxMDo3OmRlNWI6MDc1NDk3ZWUxNDE1MGNiM2I3ZThmOTQxZjAxNTY5MzUxNmQ1ZTUzMThiNWEzYzk4NGQ3NWEzNzlmM2IyMDhjNjpoOkY6Tg" href="https://protect.checkpoint.com/v2/r02/___https://data.ene.iiasa.ac.at/ngfs/%23/license___.YzJlOmlpYXNhOmM6bzpkYjlkNzM0YWJiNzc3OTZkOWFhNjVkMzJlOGU5OWMxMDo3OmRlNWI6MDc1NDk3ZWUxNDE1MGNiM2I3ZThmOTQxZjAxNTY5MzUxNmQ1ZTUzMThiNWEzYzk4NGQ3NWEzNzlmM2IyMDhjNjpoOkY6Tg" target="_blank" rel="noopener noreferrer">https://data.ene.iiasa.ac.at/ngfs/#/license</a>. Thus, while the NGFS climate scenarios are certainly a helpful tool, they do not alleviate the responsibility of users, including banks and other (financial) organisations, to design and implement their own risk management frameworks.</p> <h1><strong>Download information</strong></h1> <h2><strong>Please do not request a data download here.</strong></h2> <p>Rather, the data is available for download at the <a href="https://data.ece.iiasa.ac.at/ngfs">NGFS Scenario Explorer</a> under this <strong>download link:</strong> <a href="https://data.ece.iiasa.ac.at/ngfs/#/downloads">https://data.ece.iiasa.ac.at/ngfs/#/downloads</a>. In order to download click on <em>Guest login. </em>You will be forwarded to the downloads page. At the <strong>bottom</strong> of the <strong>downloads</strong> page you can download the data.</p> <p>The license permits use of the scenario ensemble for scientific research and commercial use, but restricts redistribution of substantial parts of the data. Please refer to the FAQ and <a href="https://data.ece.iiasa.ac.at/ngfs/#/license">legal code</a> for more information.</p> <h2><strong>About NGFS</strong></h2> <p>The Network for Greening the Financial System (NGFS) is a group of 127 central banks and supervisors and 20 observers committed to sharing best practices, contributing to the development of climate– and environment–related risk management in the financial sector and mobilising mainstream finance to support the transition toward a sustainable economy.</p> <p>This Scenario Explorer is a web-based user interface for NGFS Scenarios. This provides intuitive visualizations & display of time series data and download of the data in multiple formats.</p> <p>NGFS scenarios were produced by NGFS Workstream on Scenarios Design and Analysis in partnership with an academic consortium from the Potsdam Institute for Climate Impact Research (PIK), International Institute for Applied Systems Analysis (IIASA), University of Maryland (UMD), Climate Analytics (CA), and the National Institute of Economic and Social Research (NIESR). This work was made possible by grants from Bloomberg Philanthropies and ClimateWorks Foundation.</p> <p>The bespoke scenarios developed in Phase 4 of this project are generated by state-of-the-art well-established integrated assessment models (IAMs), namely GCAM, MESSAGE-GLOBIOM and REMIND-MAgPIE, as well as the NiGEM macroeconomic model.</p>
Data set of article : Using hypnosis in competition period to enhance self-confidence and to reduce anxiety among volleyball players
<p>Abstract: The aim of our research was to test the influence of hypnosis on the evolution of self-confidence and anxiety. Our sample included (N = 7 volleyball players) of a Tunisian Volleyball Team, aged 16 to 24, were followed daily for four weeks to enjoy their training and followed a program practicing the use of hypnosis. To assess the evolution of the psychological variables, participants completed the following questionnaire based on three measurement times (at the beginning of the experiment, after two weeks and at the end of the four weeks): The Competitive State Anxiety Inventory-2 (CSAI-2). The questionnaire (CSAI-2) was obtained statistically significant from the three times analysis of variance (Alpha = .78). A one-way model ANOVA revealed that hypnosis improved for the athletes (p < .01); self-confidence increased (p < .01) and cognitive anxiety decreased (p < .05). Correlation analysis revealed that changes in hypnosis were moderately related to changes in self-confidence (p < .05).The results of the study showed that hypnosis can enhance self-confidence and reduce cognitive anxiety. These observations allow us to guide future interventions with athletes to strengthen them psychologically.</p> <p>Key words: hypnosis, self-confident, anxiety…</p>
Data set - From plagiarism to scientific paper mills: a profile of retracted articles within the SciELO Brazil collection
<p>Data set - From plagiarism to scientific paper mills: a profile of retracted articles within the SciELO Brazil collection, published in Ethics & Behavior journal (<a href="https://doi.org/10.1080/10508422.2022.2141747">https://doi.org/10.1080/10508422.2022.2141747</a>)</p>
Hypocalcemia During Lenvatinib Treatment for Advanced Thyroid Cancer: Clinical Features and Management in a Real-Life Setting
<p><strong><em>Background:</em></strong> Several toxicities are recorded during treatment of advanced thyroid cancer (TC) with antiangiogenic drugs, including lenvatinib (LEN). Hypocalcemia was reported in registration studies, but little data are available from real-life cohorts. The aim of our study was to describe the incidence, characteristics, and the management of hypocalcemia in patients on LEN treatment. <strong><em>Methods:</em></strong> This is a retrospective cohort study of consecutive patients with advanced TC, treated with LEN for at least six months at a single tertiary center in Italy. Phosphocalcic metabolism was evaluated during treatment. <strong><em>Results:</em></strong> We included 25 patients treated for a mean of 29 ± 19 months (range 6-68 months). Hypocalcemia occurred in 6 of the 25 patients (24% [95% confidence interval 9.36-45.13%]), being of grade ≥3 in 2 of the 25 patients (8%), and recurrent in 4 of 6 patients (67%). The median time to hypocalcemia onset was 3 months (range 0.5-13 months) from starting LEN. No differences were found between patients who developed or not hypocalcemia regarding either starting/mean dose of LEN or clinicopathological characteristics. During the hypocalcemic crisis, the 2 patients with grade ≥3 hypocalcemia had low magnesium and low or inappropriately normal parathormone (PTH) levels, while 2 of 3 patients with grade 2 hypocalcemia had a secondary hyperparathyroidism. Hypocalcemia was managed with calcium oral supplementation in most cases, although up to 10% of patients required intravenous calcium treatment and transient LEN withdrawal. <strong><em>Conclusions:</em></strong> In this relatively small cohort, we observed an incidence of hypocalcemia of 24%, which is higher than that reported in the registration trial (6.9%). Both PTH-dependent and PTH-independent mechanisms explained hypocalcemia in the present cohort. Monitoring of serum calcium levels is strongly advised during the first year of LEN treatment, as hypocalcemia may be severe. More research is needed to confirm our findings and inform possible risk factors for hypocalcemia in advanced TC patients treated with LEN.</p>
The Italian midwifery core outcome set (M-COS) for healthy childbearing women and newborns: Development and initial validation study
<p>Maga G, Brigante L, Del Bo E, Cappadona R, Daniele MAS, Arrigoni C, Caruso R, Magon A. The Italian midwifery core outcome set (M-COS) for healthy childbearing women and newborns: Development and initial validation study. Midwifery. 2022 May;108:103292. doi: 10.1016/j.midw.2022.103292. Epub 2022 Feb 23. PMID: 35235891.</p> <p><strong>Abstract</strong></p> <p><strong>Objective: </strong>This study aimed to develop and validate a midwifery core outcome set (M-COS) for Italian settings based on a salutogenic framework of maternity care.</p> <p><strong>Design: </strong>A multi-phase and multi-method study was performed. In phase one, we conducted a literature review to identify a preliminary set of outcomes sensitive to midwifery care. In phase two, the qualitative and quantitative content validity of the M-COS was tested. Finally, in the third phase, construct validity was explored through a cross-sectional study to assess the psychometric properties of the M-COS through exploratory and confirmative factor analysis. This study was conducted from December 2019 to April 2020 in Italy.</p> <p><strong>Participants: </strong>Three main groups of experts/midwives were involved. Group One (n = 10) was involved in the content validity phase, while the other two groups (Group Two and Group Three) were involved in the construct validity phase (n = 300).</p> <p><strong>Results: </strong>The M-COS includes six outcome domains and thirty-one core outcomes perceived as sensitive to midwifery care, namely: mortality and morbidity (n = 6 outcomes), childbirth (n = 3), postnatal period (n = 6), maternal health (n = 11), maternal-infant bonding (n = 3), and maternal self-care (n = 2). All domains showed good evidence of internal consistency.</p> <p><strong>Conclusion: </strong>The Italian M-COS is a novel tool that will facilitate the consistent measurement of core outcomes sensitive to midwifery care from the antenatal to the postnatal period in Italian settings. This initial work will be followed by further studies, including validation by service users.</p> <p><strong>Implications for practice: </strong>The use of the M-COS in clinical practice would facilitate evidence-based data collection and thus contribute to promoting high-quality maternity care.</p>
Data set related to the article: "Gender Differences Associated with the Prognostic Value of BPIFB4 in COVID-19 Patients: A Single-Center Preliminary Study."
<p><strong>Abstract:</strong> In the ongoing global COVID-19 pandemic, male sex is a risk factor for severe disease and death, and the reasons for these clinical discrepancies are largely unknown. The aim of this work is to study the influence of sex on the course of infection and the differences in prognostic markers between genders in COVID-19 patients. Our cohort consisted of 64 adult patients (n = 34 men and n = 30 women) with PCR-proven SARS-CoV-2 infection. Further, a group of patients was characterized by a different severity degree (n = 8 high- and n = 8 low-grade individuals for both male and female patients). As expected, the serum concentrations of LDH, fibrinogen, CRP, and leucocyte count in men were significantly higher than in females. When serum concentrations of the inflammatory cytokines, including IL-6, IL-2, IP-10 and IL-4 and chemokines like MCP-1, were measured with multiplex ELISA, no significant differences between male and female patients were found. In COVID-19 patients, we recently attributed a new prognostic value to BPIFB4, a natural defensin against dysregulation of the immune responses. Here, we clarify that BPIFB4 is inversely related to the disease degree in men but not in women. Indeed, higher levels of BPIFB4 characterized low-grade male patients compared to high-grade ones. On the contrary, no significant difference was reported between low-grade female patients and high-grade ones. In conclusion, the identification of BPIFB4 as a biomarker of mild/moderate disease and its sex-specific activity would open an interesting field for research to underpin gender-related susceptibility to the disease.</p>
Data set related to the article: "Transfer of the longevity-associated variant of BPIFB4 gene rejuvenates immune system and vasculature by a reduction of CD38+ macrophages and NAD+ decline"
<p>As we age, our body experiences chronic, systemic inflammation contributing to the morbidity and mortality of the elderly. The senescent immune system has been described to have a causal role in driving systemic aging and therefore may represent a key therapeutic target to prevent pathological consequences associated with aging and extend a healthy lifespan. Previous studies from our group associated a polymorphic haplotype variant in the BPIFB4 gene (LAV-BPIFB4) with exceptional longevity. Transfer of the LAV-BPIFB4 in preclinical models halted the progression of cardiovascular diseases (CVDs) and frailty by counterbalancing chronic inflammation. In the present study, we aimed to delineate the action of systemic adeno-associated viral vector-mediated LAV-BPIFB4 gene transfer (AAV-LAV-BPIFB4) on the deleterious age-related changes of the immune system and thereby the senescence-associated events occurring in C57BL/6J mice aged 26 months. Our in vivo data showed that 26-months-old mice had a higher frequency of CD45+SA-beta Gal+ immune cells in peripheral blood than young (4-months-old) C57BL/6J mice. Notably, AAVLAV-BPIFB4 gene transfer in aged mice reduced the pool of peripheral immunosenescent cells that were shown to be enriched in the spleen. In addition, the proper tuning of the immune secretory phenotype (IL1βlow, IL6low, IL10high) associated with a significant reduction in SA-beta Gal-positive area of aorta from AAV-LAV treated mice. At the functional level, the reduction of senescenceassociated inflammation ensured sustained NAD+ levels in the plasma of AAV-LAV-BPIFB4 old mice by preventing the NADase CD38 increase in F4/80+ tissue-resident macrophages and Ly6Chigh pro-inflammatory monocytes of the spleen and bone marrow. Finally, to validate the clinical implication of our findings, we showed that Long-living-individuals (LLIs, >95 years), which delay CVDs onset, especially if LAV-carriers, were characterized by high NAD+ levels. In conclusion, the new senotherapeutic action of LAV-BPIFB4 may offer a valuable therapeutic tool to control aging and reduce the burden of its pathophysiological disorders, such as CVDs.</p>
Data-set of CO2, CH4, N2O dissolved concentrations and ancillary data in Lake Victoria (March 2018, October 2018, and June 2019)
<p>The data-base contains 4 xlsx files:</p> <ul> <li>CTD_Lavigas_123 contains vertical profiles of CTD data (water temperature, specific conductivity, pH, oxygen saturation level (%O2)), partial pressure of CO2 measured with headspace equilibration with a Licor, CH4 and N2O measured with headspace equilibration by gas chromatography on samples collected with a Niskin bottle, obtained in March-April 2018, October-November 2018, and June 2019.</li> <li>UW_Lavigas_1 contains the continuous measurements in surface waters of partial pressure of CO2 and CH4 measured by equilibration with a Los Gatos Research portable analyzer, plus CTD data and bottom depth, obtained in March-April 2018.</li> <li>UW_Lavigas_2 contains the continuous measurements in surface waters of partial pressure of CO2 and CH4 measured by equilibration with a Los Gatos Research portable analyzer, plus CTD data and bottom depth, obtained in October-November 2018.</li> <li>UW_Lavigas_3 contains the continuous measurements in surface waters of partial pressure of CO2 and CH4 measured by equilibration with a Los Gatos Research portable analyzer, plus CTD data and bottom depth, obtained in June 2019.</li> </ul> <p>For vertical profiles (CTD_Lavigas_123) water was collected with a Niskin bottle and two 60 mL borosilicate serum bottles (Wheaton) for the determination of CH4 and N2O were filled with a silicone tubing, allowed to overflow, poisoned with a saturated solution of HgCl2 (100 µL), sealed with butyl stoppers, crimped with aluminum caps, and stored at ambient temperature in the dark. Samples for the determination of pCO2 were collected from the Niskin bottle in 4 polypropylene 60 mL syringes where 30 mL of sample water were equilibrated with 30 mL of ambient air (5 min of vigorous manual shaking). The pCO2 in ambient air and in the equilibrated gas phase were determined with a Li-840 calibrated with N2 and a suite of CO2:N2 commercial mixtures (Air Liquide Belgium) with mixing ratios of 388, 813, 3788, and 8300 ppm CO2. The overall precision of pCO2 measurements was ±2.0%. Concentrations of CH4 and N2O were determined via the headspace equilibration technique (20 mL N2 headspace in 60 mL serum bottles) and measured by GC with flame ionization detection (GC-FID) and electron capture detection (GC-ECD) with a SRI 8610C GC-FID-ECD calibrated with CH4:CO2:N2O:N2 mixtures (Air Liquide Belgium) of 1, 10, 30, 509 and 2011 ppm CH4 and of 0.2, 2.0 and 6.0 ppm N2O, and using the solubility coefficients of CH4 (Yamamoto et al. 1976) and N2O (Weiss & Price 1980). The precision of measurements was ±3.9% for CH4 and ±3.2% for N2O.</p> <p>In surface waters, pCO2 and the partial pressure of CH4 (pCH4) were measured with a Los Gatos Research (LGR) off-axis integrated cavity output spectroscopy analyzer (Ultraportable Greenhouse Gas Analyzer with extended range for CH4) coupled to an equilibrator (Frankignoulle et al. 2001). The reading of pCO2 and pCH4 from the LGR was compared in the home laboratory to the values from CH4:CO2:N2 mixtures (Air Liquide Belgium) of 1, 10, 30, 509 and 2011 ppm CH4 and 431, 1088, 4,385 and 22,029 ppm CO2. The instrument did not show detectable drift between the start and the end of the fieldwork, and the factory calibration gave satisfactory readings against standards.</p> <p>Both approaches to measure pCO2 and CH4 show excellent agreement (Borges et al. 2022). Water temperature, conductivity, pH, and dissolved O2 were measured with Yellow Spring Instrument (YSI) multiprobe (YSI EXO-2). Depth was measured with a Humminbird Helix 5 G2.</p> <p><strong>References</strong></p> <p>Borges AV, L Deirmendjian, S Bouillon, W Okello, T Lambert, FAE Roland, VF Razanamahandry, NRG Voarintsoa, F Darchambeau, IA Kimirei, J-P Descy, GH Allen, C Morana (2022) Greenhouse gas emissions from African lakes are no longer a blind spot, Science Advances, 8, eabi8716, 1-17</p> <p>Frankignoulle M., A. Borges & R. Biondo (2001) A new design of equilibrator to monitor carbon dioxide in highly dynamic and turbid environments. Water Research 35/5: 1344-1347</p> <p>Yamamoto S., J.B. Alcauskas, T.E. Crozier, Solubility of methane in distilled water and seawater. J. Chem. Eng. Data 21, 78-80 (1976).</p> <p>Weiss R.F., B.A. Price, Nitrous oxide solubility in water and seawater. Mar. Chem. 8, 347-359 (1980).</p>
AuTexTification test set
<p>Test datasets for the <a href="https://sites.google.com/view/autextification/home">AuTexTification shared task</a> at IberLEF 2023. This task aims to boost research on the detection of text generated automatically by text generation models. Participants must develop models that exploit clues about linguistic form and meaning to distinguish automatically generated text from human text.</p> <p>It consists of two tasks, both for English and Spanish: </p> <p>1) Generated or Human: determine whether the text has been automatically generated or not.</p> <p>2) Model Attribution: determine what language model generated a text.</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.